Trial Information

Summary: ACOSOG Z6041: A Phase II Trial of Neoadjuvant Chemoradiation and Local Excision for uT2uNO Rectal Cancer

You have been asked to participate in this research study because you have an early stage of cancer of the rectum.  At the present time, your cancer appears to be limited to wall of the rectum and not to have spread.  The purpose of this study is to test whether a combination of chemotherapy (drugs given to fight cancer) and radiation (a treatment that involves directing high-energy waves in the form of beams at cancer cells in order to kill them so they can no longer increase in number or size) before cancer is surgically removed with a procedure called local excision can effectively treat early stage rectal cancer. We also want to find out the effect that treatment has on bowel function and on quality of life. Your participation in this study is expected to last five years for treatment.  After your treatment on this study is over, your medical condition will be followed for five years.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: October 6, 2008 at 2:28:27 PM